Altshuler Shaham’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-238
Closed -$21.3K 322
2024
Q4
$21.3K Buy
+238
New +$21K ﹤0.01% 214
2023
Q4
Sell
-504
Closed -$26.6K 267
2023
Q3
$26.6K Sell
504
-1,498
-75% -$78.6K ﹤0.01% 181
2023
Q2
$108K Buy
2,002
+229
+13% +$12K ﹤0.01% 111
2023
Q1
$88.7K Buy
1,773
+1,191
+205% +$56.1K ﹤0.01% 158
2022
Q4
$26.9K Sell
582
-61
-9% -$2.64K ﹤0.01% 324
2022
Q3
$25K Sell
643
-95
-13% -$3.81K ﹤0.01% 350
2022
Q2
$28K Sell
738
-162
-18% -$6.59K ﹤0.01% 329
2022
Q1
$40K Buy
+900
New +$39K ﹤0.01% 409
2021
Q4
Sell
-1,117
Closed -$49K 544
2021
Q3
$49K Buy
+1,117
New +$49.4K ﹤0.01% 411
2021
Q2
Sell
-912
Closed -$35K 621
2021
Q1
$35K Sell
912
-250
-22% -$9.46K ﹤0.01% 347
2020
Q4
$41K Buy
+1,162
New +$41.9K ﹤0.01% 286
2020
Q1
Sell
-325
Closed -$15K 465
2019
Q4
$15K Buy
325
+103
+46% +$4.31K ﹤0.01% 283
2019
Q3
$9K Sell
222
-39
-15% -$1.65K ﹤0.01% 291
2019
Q2
$11K Sell
261
-210
-45% -$8.08K ﹤0.01% 272
2019
Q1
$18K Buy
471
+249
+112% +$9.51K ﹤0.01% 193
2018
Q4
$8K Buy
+222
New +$8.05K ﹤0.01% 188

Other funds holding BSX

Altshuler Shaham's BSX Position: Q1 2025 in Review

Altshuler Shaham sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 238 shares — an estimated $21.3K sold.

Altshuler Shaham first reported a position in BSX in Q4 2018 and held it in 16 quarters. The position peaked at $108K in Q2 2023. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Altshuler Shaham reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Altshuler Shaham sold 238 Boston Scientific shares in Q1 2025, an estimated $21.3K.
  • Altshuler Shaham first reported a position in Boston Scientific in Q4 2018 and held it in 16 quarters.
  • Altshuler Shaham's Boston Scientific position peaked at $108K in Q2 2023.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Altshuler Shaham's 13F filing for Q1 2025, filed 15 May 2025.